Mechanical ventricular support devices in heart failure treatment
Authors:
E. Goncalvesová
Published in:
Kardiol Rev Int Med 2011, 13(1): 52-58
Category:
From Heart Failure to Heart Transplantation
Overview
The increasing prevalence of heart failure, on the one hand, and the stagnating or declining number of suitable heart donors on the other, has led to an effort to substitute the heart function with an artificial pump. During recent decades, medical and technological progress has allowed the construction of devices that support or substitute the pumping function of the heart. The authors submit a current overview of mechanical cardiac support devices and their role in the treatment of heart failure, as well as in the heart transplant programme.
Keywords:
heart failure – ventricular support devices
Sources
1. Dickstein K, Cohen-Solal A, Fillipatos G et al. Pracovná skupina Európskej kardiologickej spoločnosti pre diagnostiku a liečbu akútneho a chronického srdcového zlyhávania 2008. Odporúčania Európskej kardiologickej spoločnosti pre diagnostiku a liečbu akútneho a chronického srdcového zlyhávania 2008. Cardiol 2009; 18: 173–214.
2. Gonçalvesová E. Refraktérne srdcové zlyhávanie. Cardiol 2007; 16: 64–67.
3. Fabián J, Gonçalvesová E, Štefanková I. Zlyhávanie a transplantácia srdca. Bratislava: Herba 2007: 312.
4. Stehlik J, Edwards LB, Kucheryavaya AY et al. The registry of the International society for heart and lung transplantation: twenty-sebenth official adult heart transplant report – 2010. J Heart Lung Transplant 2010; 29: 1089–1103.
5. Lund LH, Matthews J, Aaronson K. Patient selection for left ventricular assist devices. Eur J Heart Fail 2010; 12: 434–443.
6. Gonçalvesová E, Fabián J. Mechanické podporné systémy v programe transplantácie srdca. Kardiol pre Prax 2007; 5: 20–25.
7. Netuka I, Malý J. Mechanické podpory. In: Pirk J, Málek I a kol. Transplantace srdce. Praha: Karolinum 2008: 55–72.
8. Mather PJ, Konstam MA. Newer mechanical devices in the management of acute heart failure. Heart Fail Rev 2007; 12: 167–172.
9. Gonçalvesová E, Hulman M, Olejárová I et al. Iniciálne skúsenosti s implantabilnými mechanickými podporami ľavej komory v programe transplantácie srdca v Národnom ústave srdcových a cievnych chorôb. Cardiol 2008; 17: 101–108.
10. Dickstein K, Vardas PE, Auricchio A et al. 2010 focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 2010; 31: 2677–2687.
11. Luo XJ, Hu SS, Sun HS et al. Clinical application of BVS5000 left ventricular assist device in heart failure patients. Chin Med J 2008; 121: 877–880.
12. Pacák J, Fridrich V, Zelenay J et al. Perkutánny dočasný mechanický ľavokomorový podporný obeh Impella Recover LP 2.5. pri rizikovej perkutánnej koronárnej intervencii. Opis prvej skúsenosti na Slovensku. Cardiol 2007; 16: 172–176.
13. Favaloro RR, Bertolotti A, Diez M. Adequate systemic perfusion maintained by a CentriMag during acute heart failure. Tex Heart Inst J 2008; 35: 334–339.
14. Samoukovic G, Rosu C, Giannetti N et al. The Impella® LP 5.0 as a bridge to long-term circulatory support. Interact Cardiovasc Thorac Surg 2009; 8: 682–683.
15. Studenčan M, Jesenský T, Novotný R et al. Perkutánna mechanická podpora obehu u 21-ročnej ženy s kardiogénnym šokom. Cardiol 2008; 17: 86–89.
16. Gregoric ID, Jacob LP, La Francesca S et al. The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge). Tex Heart Inst J 2008; 35: 125–129.
17. Greenberg B, Czerska B, Delgado RM et al. MOMENTUM Investigators and Coordinators. Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy. Results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to medical therapy (MOMENTUM). Circulation 2008; 118: 1241–1249.
18. Miller LW. Continuous aortic flow augmentation: not enough MOMENTUM. Circulation 2008; 118: 1223–1224.
19. Hill JD, Farrar DJ, Naka Y et al. Positive displacement ventricular assist devices. In: Frazier OH, Kirklin JK (eds). Mechanical circulatory support. ISHLT monograph series. Philadelphia: Elsevier 2006: 53–75.
20. Goldstein D, Zucker M, Pagani FD et al. Rotary ventricular assist devices. In: Frazier OH, Kirklin JK (eds). Mechanical circulatory support. ISHLT monograph series. Philadelphia: Elsevier 2006: 77–104.
21. Golding LAR, El-Banayosy Al, Kormos RL et al. Emerging left ventricular assist devices. In: Frazier OH, Kirklin JK (eds). Mechanical circulatory support. ISHLT monograph series. Philadelphia: Elsevier 2006; 205–217.
22. Copeland JG, Dowling RD, Tsau PH. Total artificial hearts. In: Frazier OH, Kirklin JK (eds). Mechanical circulatory support. ISHLT monograph series. Philadelphia: Elsevier 2006; 105–125.
23. Banner NR. When is myocardial failure reversible? In: Kirklin JK, Banner NR, Jessup M et al (eds). Advanced heart failure. Philadelphia: Elsevier 2009; 587–600.
24. Drews T, Stepanenko A, Dandel M et al. Mechanical circulatory support in patients of advanced age. Eur J Heart Fail 2010; 12: 990–994.
25. Kirklin JK, Naftel DC, Kormos RL et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant 2010; 29: 1–10.
26. Miller LW, Pagani FD, Russell SD. HeartMate II Clinical Investigators. Use of continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357: 885–896.
27. Pagani FD, Miller LW, Russell SD. HeartMate II Investigators. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009; 54: 312–321.
28. Slaughter MS, Rogers JG, Milano CA et al. The HeartMate II Investigators. Advanced hart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361: 2241–2251.
29. Meyns B, Klotz S, Simon A et al. Proof of concept. Hemodynamic response to long-term partial ventricular support with the Synergy pocket micro-pump. J Am Coll Cardiol 2009; 54: 79–86.
30. Fang JC. Rise of the machines – left ventricular assist devices as permanent therapy for advanced heart failure. N Engl J Med 2009; 361: 2282–2285.
31. Rose EA, Gelijns AC, Moskowitz AJ. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345: 1435–1443.
32. Rogers JG, Butler J, Lansman SL. INTrEPID Investigators. Chronic mechanical circulatory support for inotrope-dependent heart failure who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol 2007; 50: 741–747.
33. Frazier OH. Current status of cardiac transplantation and left ventricular assist devices. Tex Heart Inst J 2010; 37: 319–321.
34. Lietz K, Long JW, Kfoury AG et al. Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy. Analysis of the Thoratec HeartMate registry, 1998 to 2005. Circ Heart Fail 2009; 2: 3–10.
35. Lietz K, Long JW, Kfoury AG et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era. Implications for patient selection. Circulation 2007; 116: 497–505.
36. Kwon MH, Moriguchi JD, Ardehali A et al. Use of ventricular assist device as a bridge to cardiac transplantation. Impact of age and other determinants on outcomes. Tex Heart Inst J 2009; 36: 214–219.
37. Holman WL, Kormos RL, Naftel DC et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant 2009; 28: 44–50.
38. Stevenson LW, Pagani FD, Young JB et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 2009; 28: 535–541.
39. Wilson SR, Mudge GH Jr, Stewart GC et al. Evaluation for a ventricular assist device. Selecting the appropriate candidate. Circulation 2009; 119: 2225–2232.
40. Khan SN, Silver MA. Permanent ventricular assist device. In: Kirklin JK, Banner NR, Jessup M et al (eds). Advanced heart failure. Philadelphia: Elsevier 2009; 573–586.
41. Varga I, Olejárová I, Gonçalvesová E. Môže tromboelastografia ovplyvniť manažment pacientov v kardiológii a kardiochirurgii? Vnitř Lék 2009; 55: 1070–1078.
42. Murray MA, Osaki S, Edwards NM et al. Multidisciplinary approach decreases length of stay and reduces cost for ventricular assist device therapy. Interact Cardiovasc Thorac Surg 2009; 8: 84–88.
43. Lesný P, Luknár M, Solík P et al. Mechanické podporné systémy ľavej komory – komu a kedy? XV. kongres Slovenskej kardiologickej spoločnosti. Bratislava, 7.–9. október 2010.
44. PROSTHESES. www6.ufrgs.br/favet/imunovet/molecular_immunology/prostheses.html. 21. 11. 2010
45. Deng MC, Edwards LB, Hertz MI et al. International Society for Heart and Lung Transplantation. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report – 2005. J Heart Lung Transplant 2005; 24: 1182–1187.
Labels
Paediatric cardiology Internal medicine Cardiac surgery CardiologyArticle was published in
Cardiology Review
2011 Issue 1
Most read in this issue
- Cardiogenic shock
- Is the prognosis of congestive heart failure patients still so bad?
- Mechanical ventricular support devices in heart failure treatment
- Latent obstruction in outflow tract of left ventricle in patient with hypertrophic cardiomyopathy